Keep up to date with the latest developments from CERSI-PGx, including news articles, research publications, workshops, and events. This page provides timely information for researchers, industry professionals, regulators, and the public interested in pharmacogenomics.
- Latest Publications
- Upcoming Events
- Past Events Archive
LinkedIn Feed
News & Events
-
New Module Launched on CERSI-PGx Training and Education Platform
Responsive Regulatory Action from Signals in Post-Marketing Surveillance — Toxicity Case Studies This module addresses the significance of post-marketing pharmacogenomic (PGx) surveillance and its role… read article →
-
CERSI-PGx Workshop – 10 September 2026
We would like to extend an invitation to all our CERSI-PGx friends and colleagues to join us at the next CERSI-PGx on-line workshop to be… read article →
-
New CERSI-PGx Guideline published!
We are delighted to announce that the CERSI-PGx has published its latest PGx prescribing guideline. We have made recommendations for the optimisation of clozapine prescribing… read article →
-
PPIE Publication
We are pleased to share the publication of our paper, “Consistency and clarity of pharmacogenomic guidance in UK medicine patient information leaflets: A cross-sectional analysis,”… read article →
-
New CERSI-PGx Clinical Guidelines: HLA Genotyping for carbamazepine, oxcarbazepine and eslicarbazepine
We are delighted to share the publication of the second CERSI-PGx guideline on the use of HLA testing to optimise the prescribing of carbamazepine, oxcarbazepine… read article →
-
New CERSI-PGx Clinical Guidelines: Universal CYP2C19 Genotyping for Clopidogrel Prescribing
CERSI-PGx has published comprehensive UK clinical guidelines recommending universal CYP2C19 genotype testing for patients prescribed clopidogrel. Covering stroke, coronary artery disease, and peripheral arterial disease,… read article →
Learn more about each work package →
- WP1 – Developing UK-Based Guidelines
- WP2 – Pathway for Industry Pharmacogenomic Testing
- WP3 – Education and Training
- WP4 – Health Economics of PGx
- WP5 – Patient and Public Engagement